Frankly, it makes sense. The disease is terminal, and as it progresses, it becomes more and more difficult to care for these boys. The FDA allows caregiver burden endpoints for things such as Parkinson's and Alzheimer's. They should do the same here.
Get over yourself and try to be a little objective. I didn't say anything about the trial population, but in terms of statistical power, the study was small. If you know anything about statistics at all, that can't be argued. It doesn't mean the drug shouldn't be approved (I certainly think it should) but you're delusional if you think it isn't reasonable for the FDA to want a trial with a larger population, regardless of whether or not they give early approval on eteplirsen. This whole "approve on P2 and skip P3 trial" is absurd and ignorant. It's possible to have both early approval and a large P3 trial. Gray area, carrix, look into it. The world isn't black and white.
Yes, there will be a new study regardless of AA, and no, it wouldn't be a waste of time. I think AA should be given, but the P2 study was small. We need, and the FDA will demand, to see results from a larger study, as they should.
I should say if Perceptive sold so much that they are no longer a 5% holder, then they'd have to file immediately. Because they haven't, we know they still hold at least 5% of the shares.
Even if Perceptive sold one share, they'd have to file an amended 13G (or 13G/A). Because they haven't, you can assume they still hold all of their shares.
Please stop your moronic crusade. You're just cluttering the board.
a) It's not going to work no matter how hard you try.
b) If you insist on trying, contact the large institutional holders of shares; not retailers. DURRRRR...
You should appeal to the funds who own shares if you're naive to believe this will work. Retail won't have any impact, and even if every share was physically held, there would still be plenty of naked shorting.
Ha. Totally and completely random in spite of the occasional rumor. My name came about because a dozen years ago when I was in college, I played Wall Street, Jr. That is, buying and re-selling toys on eBay. I sold vintage hot wheels (HW), simpsons memorabilia (simpsons) and vintage superhero action figures (hero). Then I realized the returns on the stock market were much greater. True story.
There was another 13G filed today. By my count, that makes six 5+% holders now, with four of them in the past month. They own 35% of the float.
What? The company has $.17/share in cash. That is definitely NOT plenty of cash.
This company needs cash and has an ATM in place to raise it. (And they will.) In other words, if you are trying to bottom-feed on a dead-cat bounce, you are taking a huge risk unless you are a very skilled at day trading. This is a falling knife that you probably shouldn't touch because the knife will likely keep falling thanks to the money machine. Just a little friendly advice. I hold no position.